Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia - A randomized, placebo-controlled, double-blind safety and efficacy study

  1. Geissler, K.
  2. Liu Yin, J.A.
  3. Ganser, A.
  4. Sanz, M.A.
  5. Szer, J.
  6. Raghavachar, A.
  7. Hoelzer, D.
  8. Martinez, C.
  9. Taylor, K.
  10. Kanz, L.
  11. To, L.B.
  12. Archimbaud, E.
Journal:
Annals of Hematology

ISSN: 0939-5555

Year of publication: 2003

Volume: 82

Issue: 11

Pages: 677-683

Type: Article

DOI: 10.1007/S00277-003-0737-7 GOOGLE SCHOLAR

Sustainable development goals